Stroke risk following traumatic brain injury: Systematic review and meta-analysis by Turner, Grace M et al.
Systematic Review
Stroke risk following traumatic
brain injury: Systematic review
and meta-analysis
Grace M Turner1 , Christel McMullan1,2,3,
Olalekan Lee Aiyegbusi1,2,3,4,5,6, Danai Bem3, Tom Marshall3,
Melanie Calvert1,2,3,4,5,6, Jonathan Mant7 and Antonio Belli2
Abstract
Background: Traumatic brain injury is a global health problem; worldwide, >60 million people experience a traumatic brain
injury each year and incidence is rising. Traumatic brain injury has been proposed as an independent risk factor for stroke.
Aims: To investigate the association between traumatic brain injury and stroke risk.
Summary of review: We undertook a systematic review of MEDLINE, EMBASE, CINAHL, and The Cochrane Library
from inception to 4 December 2020. We used random-effects meta-analysis to pool hazard ratios for studies which
reported stroke risk post-traumatic brain injury compared to controls. Searches identified 10,501 records; 58 full texts
were assessed for eligibility and 18 met the inclusion criteria. The review included a large sample size of 2,606,379
participants from four countries. Six studies included a non-traumatic brain injury control group, all found traumatic brain
injury patients had significantly increased risk of stroke compared to controls (pooled hazard ratio 1.86; 95% confidence
interval 1.46–2.37). Findings suggest stroke risk may be highest in the first four months post-traumatic brain injury, but
remains significant up to five years post-traumatic brain injury. Traumatic brain injury appears to be associated with
increased stroke risk regardless of severity or subtype of traumatic brain injury. There was some evidence to suggest an
association between reduced stroke risk post-traumatic brain injury and Vitamin K antagonists and statins, but increased
stroke risk with certain classes of antidepressants.
Conclusion: Traumatic brain injury is an independent risk factor for stroke, regardless of traumatic brain injury severity
or type. Post-traumatic brain injury review and management of risk factors for stroke may be warranted.
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Introduction
Traumatic brain injury (TBI) is a global health prob-
lem; worldwide, more than 60 million people experience
a TBI each year and incidence is rising.1 Increased inci-
dence of TBI has been attributed to increased falls in
elderly populations, armed conflict, and sports-related
injury in high-income countries, and increased road
traffic accidents in low-/middle-income countries.2,3
Advances in critical care, imaging, and the reorgan-
ization of trauma health systems have led to a reduction
in TBI-related mortality.4 However, increased survival
rates results in more people living with the long-term
effects of TBI. These long-term effects are wide-ranging,
including physical, psychological, and cognitive disabil-
ities, and can cause huge burden at individual, family,
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and societal levels.5 Long-term impacts are not exclu-
sive to severe TBI and are often experienced by patients
with mild and moderate TBI.6
TBI has also been associated with long-term risk of
neurological diseases, including dementia, Parkinson’s
disease, Alzheimer’s disease, and epilepsy.7–10 TBI has
been proposed as an independent risk factor for
stroke;11 however, to our knowledge, no systematic
reviews have explored stroke risk post-TBI. Stroke is
a leading cause of death and disability worldwide, but
stroke prevention medication and lifestyle change can
reduce stroke risk.12 Therefore, understanding the asso-
ciation between TBI and stroke is important to help
inform healthcare for TBI patients. Characterizing
stroke risk post-TBI is particularly important given
the changing epidemiology of TBI in high-income
countries among the elderly and the fact that older
age is an independent risk factor for stroke. The aim
of this review was to investigate the association between
TBI and risk of stroke.
Material and methods
The review protocol was registered on PROSPERO
prior to conducting literature searches
(CRD42019121149).13 The review methodology and
reporting is in accordance with the preferred reporting
items for systematic reviews and meta-analyses
(PRISMA) guidance.14
Eligibility criteria
Studies were eligible if they included adult participants
(18 years) who had experienced a TBI (any severity)
and reported frequency, incidence, or risk estimates of
stroke and/or transient ischemic attack (TIA) at any
time point post-TBI. Studies of mixed populations
were eligible if it was possible to extract data of TBI
participants.
Eligible study designs were controlled, cohort, cross-
sectional, and case control studies. Only peer-reviewed,
full text publications or theses were included. To avoid
language bias, non-English papers were eligible.
Information sources and search strategy
Searches were performed with no publication date
restrictions in the following bibliographic databases:
MEDLINE, EMBASE, CINAHL, and The Cochrane
Library. Grey literature was searched from the follow-
ing sources: Grey Matters by CADTH, OpenGrey, and
Epistemonikos. Reference lists of relevant studies were
also reviewed. The initial search was performed from
inception to 14 December 2018, followed by an updated
search from 2018 to 4 December 2020.
A combination of text words and index terms related
to the condition (TBI) and the outcome (stroke/TIA)
were utilized (Supplementary Figure 1).
Study selection, data extraction, and critical
appraisal
Literature search results were exported to EndNote
V.X8.0 (Thomson Reuters, New York) and duplicates
removed. Titles and abstracts of search results were
screened and full texts obtained for potentially eligible
studies. A standardized, pre-determined eligibility cri-
teria checklist was used to select eligible studies
(Supplementary Table 1). Data were extracted on
study design, population, outcomes, and findings
using a standardized, piloted data extraction form
(Supplementary Table 2). An adapted version of the
reporting of studies conducted using observational rou-
tinely collected data checklist was used to assess quality
of included studies.15
All study selection, data extraction, and quality
assessment processes were conducted independently
and in duplicate by three authors (GMT, CM, and
OLA); discrepancies were resolved by an additional
reviewer (AB).
Data synthesis and statistical analysis
A random effects meta-analysis pooled hazard ratios
(HRs) for studies which reported stroke risk post-TBI
compared to non-TBI controls. The meta-analysis was
performed using Review Manager Version 5.3.
(Copenhagen: The Nordic Cochrane Centre, The
Cochrane Collaboration, 2014). Studies without a
non-TBI comparator were narratively summarized
and tables were created to facilitate comparisons. A
narrative subgroup analysis was conducted for studies
which reported time to stroke onset post-TBI; severity
or subtype of TBI; and stroke type (ischemic and
hemorrhagic).
Data availability
Data are available on request.
Results
Searches identified 10,501 records, of which 58 full texts
were assessed for eligibility and 18 met the inclusion
criteria (Figure 1).
Study characteristics
The 18 studies included 2,606,379 participants and were
from the United States,16–24 Taiwan,25–31 Croatia,32
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and Denmark.33 All were retrospective cohort studies
and eight different data sources were used (Table 1),
most commonly the Taiwan National Health
Insurance Research Database16–18,20,21,31 and United
States Medicare administrative claims data.24–30 The
eligibility criteria and definitions of TBI and stroke
for included studies are summarized in Supplementary
Table 3.
Six studies explored stroke risk post-TBI compared
to non-TBI controls (Table 1).19,26–29,31 Eight studies
investigated the association of stroke risk post-TBI
with specific exposures: antidepressants;18,20 statins;21
oral anticoagulants;16,33 traumatic subarachnoid hem-
orrhage (tSAH);23 acupuncture;30 and insomnia.25 Two
studies reported frequency of stroke post-TBI without a
comparator22,32 and two studies compared stroke inci-
dence pre- and post-TBI.17,24
Risk of stroke post-TBI
Stroke risk compared to non-TBI controls. Of the six studies
that included a non-TBI control group, all found TBI
patients had statistically significantly increased risk of
stroke compared to controls. This association
remained when confounding variables were adjusted
for (Table 2). All studies matched on or adjusted for
age and sex; the list of variables each study adjusted for
is detailed in Supplementary Table 4. The pooled
adjusted HR was 1.86 (95% confidence interval (CI)
1.46–2.37) (n¼ 544,762 TBI patients and 1,692,865
controls) (Figure 2).
Stroke risk pre- and post-traumatic brain injury. Two studies
investigated stroke rates pre- and post-TBI.17,24 Both
studies reported higher incidence rates of ischemic and
hemorrhagic stroke post-TBI compared to pre-TBI
(Table 2).
Stroke risk associated with specified exposures. Three studies
explored stroke risk associated with exposure to stroke
prevention medication post-TBI (Table 3). For patients
who had been prescribed Vitamin K antagonists
(VKAs) prior to TBI, continuation or resumption of
these drugs after TBI was associated with reduced
stroke risk post-TBI compared to patients who had
VKA prescriptions stopped post-TBI (Albrecht
Figure 1. PRISMA flow chart.
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et al.:16 relative risk 0.83; 95% CI 0.72–0.96 and Staerk
et al.:33 HR 0.58; 95% CI 0.37–0.90). However, no
association was found for continuation or resumption
of novel oral anticoagulants (NOACs) (HR 0.85; 95%
CI 0.43–1.68). Prescription of statins post-TBI was
associated with reduced risk compared to TBI patients
not prescribed statins post-TBI (relative risk 0.86; 95%
CI 0.81–0.91).
Two studies investigated antidepressant use in TBI
patients aged 65 years, both used administrative
claims data from United States Medicare beneficiaries
between 2006 and 2010. Khokhar et al.20 reported,
compared to no use of antidepressants post-TBI, new
use (i.e. not prescribed before TBI) of serotonin nor-
epinephrine reuptake inhibitors (SNRIs) and phenylpi-
perazine antidepressants (PPAs) were associated with
increased risk of ischemic stroke (relative risk 1.36;
95% CI 1.06–1.73 and 1.31; 95% CI 1.02–1.68, respect-
ively). They found new use of selective serotonin reup-
take inhibitors (SSRIs) was associated with increased
risk of hemorrhagic stroke (relative risk 1.26; 95% CI
1.06–1.50). However, no associations were found for
other antidepressant drug classes (Table 3). Albrecht
et al.18 found, compared to tricyclic antidepressants
(TCAs), SSRI use was associated with increased risk
of hemorrhagic stroke (risk ratio 2.47; 95% CI 1.30–
4.70). However, other antidepressant drug class com-
parisons were not associated with stroke risk (Table 3).
Exposures reported in the other three studies were
insomnia,25 acupuncture,30 and tSAH.23 TBI patients
with new onset insomnia (i.e. insomnia occurring
post-TBI) had a 2-fold increased stroke risk (HR
2.28; 95% CI 1.70–3.06) compared to insomnia patients
without TBI.25 Acupuncture treatment post-TBI was
associated with decreased stroke risk compared to
TBI patients not receiving acupuncture (HR 0.59;
95% CI 0.50–0.69).30 TBI patients with tSAH had
decreased stroke risk compared to TBI patients without
tSAH (HR 0.77; 95% CI 0.63–0.94).
Time to stroke onset post-TBI
Chen et al.26 found stroke risk post-TBI was highest in
the first three months of follow-up (HR 10.21; 95% CI
8.71–11.96), but remained significantly higher than
non-TBI controls at five years follow-up (HR 2.32;
95% CI 2.17–2.47) (Table 2).
Albrecht et al.17 reported stroke incidence rates for
TBI patients were highest two and four month’s post-
discharge and there was a steep decrease between four
and 12 months post-discharge: incidence rates (per
1000) for ischemic stroke at two months 183.5; four
months 112.3; six months 84.8; eight months 69.9; 10
months 70.3; 12 months 78.1, and hemorrhagic stroke
at two months 98.5; four months 36.1; six months 17.3;
eight months 11.7; 10 months 12.8; 12 months 8.2.
Similarly, Albrecht et al.17 found stroke rates post-
TBI were elevated in the first three months after dis-
charge and leveled out between three and 24 months for
ischemic stroke and 12 and 24 months for hemorrhagic
stroke (Supplementary Figure 2).
In a subgroup analysis of people who survived
longer than 12 months, Lee et al.27 found TBI patients’
stroke risk, compared to non-TBI controls, remained
statistically significant (HR 1.38; 95% CI, 1.20–1.59).
Four studies reported average time between TBI and
onset of stroke: Ao et al.25 0.93 years (mean follow-up
2.71 years; standard deviation (SD) 0.69); Belavic
et al.32 8.56 days (mean follow-up 29.13 days; SD
27.16); Lee et al.27 1.12 years (mean follow-up 1.94
years; SD 1.18); Chen et al.26 1.49 years (maximum
follow-up five years).
Two studies reported frequency of stroke diagnosed
during acute hospitalization for TBI. Kowalski et al.22
found 2.5% (159/6488) of moderate to severe TBI
patients had an ischemic stroke (median hospital dur-
ation 25 days, range 4–125 days). Belavic et al.32 found
7.5% (23/306) of TBI patients had a stroke (mean time
to stroke after TBI 7 8 days and mean hospital dur-
ation 29 27 days).
Severity and subtype of TBI
Two studies had populations of mild TBI patients, both
reported increased stroke risk post-TBI compared to
non-TBI controls: Lee et al.27 HR 1.46 (95% CI
1.33–1.62) and Liu et al.29 HR 1.65 (95% CI 1.47–
1.85) (Table 2). In a secondary analysis stratified by
Figure 2. Random effects meta-analysis pooled estimates for stroke risk post-TBI compared to non-TBI controls (n¼6 studies;
544,762 TBI patients and 1,692,865 controls).
International Journal of Stroke, 16(4)
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trauma severity, Burke et al.19 found ischemic stroke
risk remained significantly higher than controls regard-
less of severity (tertile 1 (lowest severity): HR 1.10; 95%
CI 1.01–1.20, tertile 2: HR 1.29; 95% CI 1.16–1.43,
tertile 3 (highest severity): HR 1.25; 95% CI 1.16–
1.35). Similarly, Liao et al.28 found increased risk of
stroke post-TBI compared to controls for all types of
TBI: mild TBI: HR 1.74 (95% CI 1.57–1.93); severe
TBI: HR 2.04 (95% CI 1.89–2.20); skull fracture: HR
3.00 (95% CI 2.42–3.71).
In a secondary analysis of trauma subtype, Burke
et al.19 found increased ischemic stroke risk compared
to controls regardless of subtype: skull fracture HR
1.21 (95% CI 1.05–1.41); concussion HR 1.27 (95%
CI 1.17–1.37); intracranial bleeding HR 1.21 (95% CI
1.12–1.31); other intracranial injury HR 1.38 (95% CI
1.07–1.76); and unspecified HR 1.33 (95% CI 1.27–
1.40). Chen et al.26 found stroke risk, compared to con-
trols, was more pronounced for TBI patients with skull
fracture at three months (skull fracture: HR 19.98; 95%
CI 14.73–27.22 vs. without skull fracture: HR 9.75;
95% CI 8.31–11.45), one year (skull fracture: HR
8.39; 95% CI 7.47–10.89 vs. without skull fracture:
HR 4.44; 95% CI 4.00–4.93), and five years (skull frac-
ture: HR 3.54; 95% CI 2.86–4.37 vs. without skull frac-
ture: HR 2.26; 95% CI 2.12–2.42).
Stroke type
Five studies reported stroke risk post-TBI by stroke type.
Eric Nyam et al.31 found higher risk of hemorrhagic
stroke post-TBI, compared to controls, than ischemic
stroke (HR 6.02; 95% CI 4.80–7.55 and HR 2.10; 95%
CI 1.81–2.43, respectively) Chen et al.26 reported higher
risk of stroke post-TBI, compared to controls, for sub-
arachnoid and intra-cerebral hemorrhagic stroke types
than ischemic and unspecific strokes (subarachnoid hem-
orrhage: HR 4.89; 95% CI 3.81–7.19, intra-cerebral hem-
orrhage: HR 6.33; 95% CI 5.60–7.83, ischemic: HR 1.43;
95% CI 1.31–1.56, unspecified: 2.21; 95% CI 1.99–2.44).
Similarly, Albrecht et al.17 and Glass et al.24 found higher
incidence rate ratios for hemorrhagic stroke post-TBI,
compared to pre-TBI, than for ischemic stroke (Table
2). In contrast, Liu et al.29 found higher cumulative inci-
dence rates post-TBI for ischemic stroke compared to
hemorrhagic stroke (8.9%; 95% CI 7.8–10.0 vs. 2.7%;
95% CI 2.1–3.3, respectively) and similar adjusted HRs
for stroke risk post-TBI, compared to controls, for both
stroke subtypes (ischemic: HR 1.62; 95% CI 1.43–1.84
vs. hemorrhagic: HR 1.73; 95% CI 1.36–2.20).
Study quality
Critical appraisal of included studies (Supplementary
Table 5) identified that the study design – including
setting, recruitment, and follow-up dates – and eligibil-
ity criteria were well described by all included studies.
All studies, except one, clearly reported the clinical
codes used to identify exposures and outcomes; how-
ever, only three studies referenced validation studies for
these clinical codes and nine studies did not provide a
complete list of clinical codes for confounders and
other variables. Statistical methods were described
well by most studies; however, none of the studies
explained how missing data were addressed.
Furthermore, none of the studies clearly described
data cleaning methods and most studies (n¼ 10) did
not report population selection based on data quality,
data availability, and linkage.
Discussion
This systematic review is the first to explore the associ-
ation between TBI and stroke risk. The meta-analysis
found TBI patients have 86% increased risk of stroke
compared to non-TBI controls (HR 1.86; 95% CI 1.46–
2.37). Stroke risk may be highest in the first four
months post-TBI, but remains significant five years
post-TBI. TBI is associated with increased stroke risk
regardless of TBI severity or subtype. Furthermore,
TBI is associated with increased risk of both ischemic
and hemorrhagic stroke. VKAs, statins, and acupunc-
ture use is associated with reduced stroke risk post-TBI;
however, no association was found for NOAC use.
Some classes of antidepressants – SNRIs, PPAs, and
SSRIs – are associated with increased stroke risk
post-TBI.
Our findings suggest TBI is an independent risk
factor for stroke regardless of TBI severity or subtype,
even if it is mild and patients experience a good recov-
ery. This is particularly noteworthy because 70–90% of
TBIs are mild.34 Stroke is the second leading cause of
death and third leading cause of disability worldwide;
however, urgent treatment can prevent stroke-related
death and long-term disability.35,36 Therefore, it may
be beneficial to inform TBI patients of their potential
increased stroke risk and educate them to recognize and
respond urgently to stroke symptoms.
Primary stroke prevention is important to reduce
stroke incidence and subsequent stroke-related death
and disability; therefore, clinicians should review
patients’ stroke risk post-TBI and consider administer-
ing stroke prevention medication and lifestyle advice.
Our review found some evidence to suggest an associ-
ation between reduced stroke risk post-TBI and the
stroke prevention drugs VKAs and statins.
Furthermore, Khokhar et al.21 found statin use post-
TBI was also associated with decreased mortality,
depression, Alzheimer’s disease, and related dementias.
However, stroke prevention drugs are often stopped
International Journal of Stroke, 16(4)
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after an individual has experienced a TBI; Albrecht
et al.16 found 55% of patients who had been prescribed
warfarin prior to TBI were not prescribed warfarin
post-TBI,16 and Orlando37 found a statin discontinu-
ation rate of 38% post-TBI for patients who took sta-
tins prior to TBI.37 Other research has found older age
and risk of falls are common barriers to clinicians’ pre-
scribing stroke prevention drugs.38 This is particularly
relevant given the shift in TBI epidemiology in high-
income countries to falls in the elderly.3 Future research
is required to investigate the effectiveness of stroke pre-
vention medication post-TBI and related adverse events
to help inform clinicians’ prescribing and facilitate
shared decision making. Future research should also
explore clinical and demographic characteristics asso-
ciated with increased stroke risk post-TBI to identify
individuals most at risk of stroke post-TBI and help
clinicians’ tailor preventative healthcare.
Stroke risk may be highest in the first four months
post-TBI; therefore, this time period is critical to educate
patients about stroke risk and symptoms, and to admin-
ister stroke prevention medication and lifestyle advice.
Importantly, stroke prevention medication, particularly
VKAs and statins, should be re-started for patients who
were prescribed these drugs prior to TBI. However,
sequelae from TBI, such as physical and cognitive dis-
ability, may impair patients’ ability to engage with life-
style change, adhere to medication, or recognize and
respond to stroke symptoms. Therefore, rehabilitation
post-TBI, including the role of carers and family mem-
bers, should provide ongoing support for stroke preven-
tion. Future research is required to further understand
the temporal nature of stroke risk post-TBI.
Our review found some evidence to suggest an asso-
ciation between some classes of anti-depressants and
increased stroke risk post-TBI. This potential associ-
ation is important given that many people experience
anxiety and depression post-TBI,5 which are often trea-
ted with antidepressants. Khokhar et al.20 found that a
third of TBI patients were prescribed new use of anti-
depressants. A recent systematic review found anti-
depressant use is associated with increase stroke risk
(risk ratio 1.41; 95% CI 1.13–1.69).39 However, a
study published since that review suggested antidepres-
sants strongly inhibiting serotonin reuptake may be
associated with a small decrease in the rate of ischemic
stroke.40 Further research is required into the safety of
antidepressants specifically for TBI patients.
The mechanism for increased stroke risk post-TBI is
unknown and is an area for future research; however, a
number of hypotheses have been suggested. Damage to
the cerebrovascular system caused by TBI could cause
stroke through clot formation, damaged arteries, dis-
section, or increased intracranial pressure and blood
pressure.26 This could be identified by routine screening
for damage to the cerebral vasculature post-TBI and is
an area for future research. Alternatively, increased
stroke risk may be due to lifestyle changes post-TBI,
such as a more sedentary lifestyle due to physical, cog-
nitive, or psychological long-term effects.28 Finally,
TBI patients may be more likely to be prescribed anti-
psychotic and antidepressant drugs for TBI-related psy-
chiatric and psychological disorders. These drugs have
been associated with increased stroke risk.18,21,41
The review is methodologically robust; all screening,
data extraction, and quality assessment processes were
completed in duplicate. Non-English language papers
were eligible to reduce language bias, although none
were eligible. However, only peer-reviewed journal art-
icles or theses were eligible which may introduce pub-
lication bias. The review included a large sample size of
2,606,379 participants from four countries. However,
only six out of the 18 studies compared stroke risk to
non-TBI controls and studies were heterogeneous in
terms of study population and duration of follow-up.
Furthermore, all included studies were retrospective
cohort studies which used data collected for routine
clinical practice. Potential sources of bias from use of
routine data for observational research include mis-
classification bias, missing data, unmeasured confound-
ing, and changes in coding practices or database
eligibility criteria.15 In addition, information on
stroke type, TBI classification, and TBI severity were
missing from the majority of studies. The association of
stroke risk with treatment (in both directions) may be
confounded by indication bias. Therefore, the review
findings should be interpreted cautiously. The included
studies were generally good quality in terms of study
design and reporting; however, none of the studies
clearly reported data cleaning processes and there was
a lack of reporting of population selection based on
data quality, availability, and linkage. This information
is important because choice of data cleaning methods
and population selection can affect study findings and
reproducibility. Finally, most of the studies included
administrative databases, which implies that the TBI
definition might be inconsistent. However, in practice,
these databases provide large sample sizes, thereby
increasing reliability and validity.
Our findings suggest TBI is an independent risk
factor for stroke, regardless of TBI severity or subtype.
There is some evidence to suggest stroke risk may be
highest in the first four months post-TBI; however, it
remains increased up to five years post-TBI. VKAs and
statins may reduce stroke risk post-TBI; however, they
are frequently stopped post-TBI. Post-TBI review and
management of risk factors for stroke may be war-
ranted to mitigate the excess risk of stroke associated
with TBI. Future research should investigate which
subgroups are most at risk of stroke post-TBI; the
International Journal of Stroke, 16(4)
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temporal nature of stroke risk post-TBI; the effective-
ness of stroke prevention medication post-TBI; the
safety of antidepressants post-TBI; and the mechanism
of stroke risk post-TBI.
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